In type 1 diabetic rats, liraglutide inhibits cardiac steatosis, oxidative stress, and apoptosis through activating the activated protein kinase (AMPK)-sirtuin 1 (Sirt1) pathway [7]. Here, SIRT1 is linked to type 1 diabetes mellitus.